Cancer Research Landon Prizes for Basic and Translational Cancer Research  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 49, 5918-5921, November 1, 1989]
© 1989 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seetharam, S.
Right arrow Articles by Kraemer, K. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seetharam, S.
Right arrow Articles by Kraemer, K. H.

Ultraviolet Mutagenesis in a Plasmid Vector Replicated in Lymphoid Cells from a Patient with the Melanoma-prone Disorder Dysplastic Nevus Syndrome

Saraswathy Seetharam1, Haywood L. Waters, Michael M. Seidman and Kenneth H. Kraemer

Laboratory of Molecular Carcinogenesis, National Cancer Institute, Bethesda, Maryland 20892 [S. S., H. L. W., K. H. K.], and Otsuka Pharmaceutical Corporation, Rockville, Maryland 20854 [M. M. S.]

The hereditary dysplastic nevus syndrome (DNS) is an autosomal dominant disorder in which affected individuals have increased numbers of dysplastic (premalignant) nevi and a >100-fold increased risk of developing cutaneous melanoma. Epstein-Barr virus-transformed lymphoblastoid cell lines from patients with hereditary DNS have been shown to be hypermutable to UV radiation (M. I. R. Perera et al., Cancer Res., 46: 1005–1009, 1986). To examine the mechanism involved in this UV hypermutability, we used a shuttle vector plasmid, pZ189, which carries a 160-base pair marker gene, supF, and can replicate in human cells. pZ189 was treated with UV radiation and transfected into DNS6BE, a lymphoblastoid cell line from a patient with hereditary DNS. Plasmid survival after UV was similar with the DNS6BE line and with a lymphoblastoid cell line from a normal donor. Plasmid mutation frequency was greater with the DNS line in accord with the DNS cellular hypermutability. Base sequence analysis was performed on 69 mutated plasmids recovered from the DNS line. There were significantly more plasmids with single base substitution mutations (P < 0.01) in comparison to UV-treated plasmids passed through normal fibroblasts. pZ189 hypermutability and an increased frequency of single base substitutions was previously found with a cell line from a melanoma-prone xeroderma pigmentosum patient. These differences may be related to the increased melanoma susceptibility in both DNS and xeroderma pigmentosum.

1 To whom requests for reprints should be addressed, at Laboratory of Molecular Carcinogenesis, Building 37, Room 3E24, Bethesda, MD 20892.

Received 3/20/89. Revised 6/19/89. Accepted 8/ 4/89.




This article has been cited by other articles:


Home page
JNCI J Natl Cancer InstHome page
P. Sarkar-Agrawal, I. Vergilis, N. E. Sharpless, R. A. DePinho, and T. M. Runger
Impaired Processing of DNA Photoproducts and Ultraviolet Hypermutability With Loss of p16INK4a or p19ARF
J Natl Cancer Inst, December 1, 2004; 96(23): 1790 - 1793.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
K. H. Kraemer
NRAS Hypermutability in Familial Melanoma With CDKN2A Mutations--Cause and Effect?
J Natl Cancer Inst, June 4, 2003; 95(11): 768 - 769.
[Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
M. Eskandarpour, J. Hashemi, L. Kanter, U. Ringborg, A. Platz, and J. Hansson
Frequency of UV-Inducible NRAS Mutations in Melanomas of Patients With Germline CDKN2A Mutations
J Natl Cancer Inst, June 4, 2003; 95(11): 790 - 798.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
M. T. Landi, A. Baccarelli, R. E. Tarone, A. Pesatori, M. A. Tucker, M. Hedayati, and L. Grossman
DNA Repair, Dysplastic Nevi, and Sunlight Sensitivity in the Development of Cutaneous Malignant Melanoma
J Natl Cancer Inst, January 16, 2002; 94(2): 94 - 101.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. E. Tobi, D. D. Levy, M. M. Seidman1, and K. H. Kraemer1
Sequence-dependent mutations in a shuttle vector plasmid replicated in a mismatch repair deficient human cell line
Carcinogenesis, July 1, 1999; 20(7): 1293 - 1301.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1989 by the American Association for Cancer Research.